Search Results - "Bosiers, Marc"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions by Bosiers, Marc, MD, Deloose, Koen, MD, Callaert, Joren, MD, Moreels, Nathalie, MD, Keirse, Koen, MD, Verbist, Jürgen, MD, Peeters, Patrick, MD

    Published in Journal of vascular surgery (01-10-2011)
    “…Objectives This study investigated the results with primary stenting using the Protégé EverFlex 200-mm-long self-expanding nitinol stent (ev3 Endovascular Inc,…”
    Get full text
    Journal Article
  8. 8

    Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial by Böhme, Tanja, Noory, Elias, Brechtel, Klaus, Scheinert, Dierk, Bosiers, Marc, Beschorner, Ulrich, Zeller, Thomas

    Published in Journal of endovascular therapy (01-04-2021)
    “…Purpose: To evaluate the 36-month technical and clinical outcome after implantation of the 25-cm Viabahn endoprosthesis with Propaten bioactive surface in…”
    Get full text
    Journal Article
  9. 9

    Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: The Viabahn-25 cm Trial by Zeller, Thomas, Peeters, Patrick, Bosiers, Marc, Lammer, Johannes, Brechtel, Klaus, Scheinert, Dierk, Rastan, Aljoscha, Noory, Elias, Beschorner, Ulrich

    Published in Journal of endovascular therapy (01-12-2014)
    “…Purpose: To confirm the performance and safety of the 25-cm Viabahn endoprosthesis with Propaten bioactive surface when used in the treatment of de novo and/or…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Do device characteristics impact outcome in carotid artery stenting? by Hart, Joseph P., Peeters, Patrick, Verbist, Jurgen, Deloose, Koen, Bosiers, Marc

    Published in Journal of vascular surgery (01-10-2006)
    “…The study was conducted to identify patient and procedural parameters that negatively impact the 30-day rates for stroke, death and transient ischemic attack…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Drug-eluting bioabsorbable magnesium stent by Di Mario, Carlo, Griffiths, Huw, Goktekin, Omer, Peeters, Nicolas, Verbist, Jan, Bosiers, Marc, Deloose, Koen, Heublein, Bernhard, Rohde, Roland, Kasese, Victor, Ilsley, Charles, Erbel, Raimund

    Published in Journal of interventional cardiology (01-12-2004)
    “…Current stent technology is based on the use of permanent implants that remain life long in the vessel wall, far beyond the time required for the prosthesis to…”
    Get more information
    Journal Article
  20. 20